AI 100
Capital IA
Mapa de la industria de IA
ETF de IA
Idioma
English
简体中文
日本語
한국어
Deutsch
Français
Español
Português
Iniciar sesión / Registrarse
AI 100
Capital IA
Mapa de la industria de IA
ETF de IA
Idioma
English
简体中文
日本語
한국어
Deutsch
Français
Español
Português
← Volver a inversores
Capital Group
投资主体(类型未细分)
Sitio oficial ↗
Mínimo de inversión verificado
≥$10.03M
Casos de inversión
3
Años desde la fundación
—
Inversiones representativas
Anthropic
$965B
↗
Legora
$8.8B
↗
Insilico Medicine(英矽智能)
$2.65B
↗
Cartera
Novedades de participadas
Aportaciones individuales
Fondos específicos
Información
Buscar
#
Empresa
Capitalización / valoración
USD
Financiación acumulada
USD
Última financiación / salida a bolsa
Principales inversores
01
Anthropic
美国
$965B
Valoración privada
2026-05-28
Fuentes · 1
Anthropic raises $65B Series H at $965B valuation \ Anthropic ↗
2026-10-22
≥$108.45B
Mínimo verificado
$65B
Series H
2026-05-28
Fuentes · 1
Anthropic raises $65B Series H at $965B valuation \ Anthropic ↗
2026-10-22
Altimeter Capital
Dragoneer Investment Group
Greenoaks Capital
Sequoia Capital
Capital Group
Coatue Management
Otros inversores · 52
D1 Capital
GIC
ICONIQ Capital
XN
D.E. Shaw Ventures
Founders Fund
MGX
Fidelity Investments
Lightspeed Venture Partners
Spark Capital
Amazon
Baillie Gifford
Blackstone
General Catalyst
Insight Partners
Jane Street
T. Rowe Price
AMP PBC
NX1
Temasek
Brookfield
DST Global
NTTVC
Micron
Samsung
SK Hynix
BlackRock
D1
Goldman Sachs Alternatives
Qatar Investment Authority
TPG
Accel
Addition
Alpha Wave
Appaloosa
Bessemer Venture Partners
JPMorgan
Menlo Ventures
Morgan Stanley Investment Management
Sands
TowerBrook
Whale Rock
ARK Invest
General Atlantic
Ontario Teachers
WCM
Google
SK Telecom
Salesforce Ventures
Sound Ventures
Zoom Ventures
LG Technology Ventures
26
Legora
瑞典/美国
$8.8B
Valoración privada
2026-10-21
Fuentes · 1
Legora raises $550 million Series E at $8.8 billion valuation to accelerate growth - Legora ↗
2026-10-22
≥$1.1B
Mínimo verificado
$550M
Series E
2026-10-21
Fuentes · 1
Legora raises $550 million Series E at $8.8 billion valuation to accelerate growth - Legora ↗
2026-10-22
Atreides Management
Baron Capital
Capital Group
Fidelity Investments
Glade Brook
J.P. Morgan
Otros inversores · 10
Accel
Benchmark
Bessemer Venture Partners
General Catalyst
ICONIQ Capital
Insight Partners
Menlo Ventures
Redpoint Ventures
Salesforce Ventures
Sands
57
Insilico Medicine(英矽智能)
3696.HK · 美国/中国
$2.65B
Capitalización bursátil
Fecha no indicada
Fuentes · 1
Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025's Largest Hong Kong Biotech IPO ↗
2026-10-22
≥$110M
Mínimo verificado
IPO / salida a bolsa
2025-12-30
Value Partners PE Fund
Eli Lilly
Tencent
Oaktree Capital Management
Schroders(施罗德)
Temasek
Otros inversores · 14
UBS
China Asset Management(华夏基金)
Pacific Asset Management(太平洋资产)
CPIC Investment Management HK
E Fund Management(易方达基金)
Fullgoal Fund Management(富国基金)
Harvest Global Investments(嘉实国际)
Taikang Life Insurance(泰康人寿)
RTW Investments
Exome Asset Management
Infini Capital Management(无极资本)
Capital Group
Mirae Asset Securities Co., Ltd.
OrbiMed Advisors IV Limited